CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $335,599,669
- in 73 filings, $334.8M under 10b5-1 plans
Net −$335,599,669. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | PATUSKY CHRISTOPHER Director | Option exercise | +1,210 | $132.30 | $160K | 3,350 |
| 2026-11-09 | PATUSKY CHRISTOPHER Director | Sale | −1,210 | $580.00 | $702K | 2,140 |
| 2026-11-09 | PATUSKY CHRISTOPHER Director | Option exercise · Stock Option | −1,210 | 3,000 | ||
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −494 | $583.80 | $288K | 325,563 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −840 | $584.70 | $491K | 324,723 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $585.63 | $164K | 324,443 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $556.52 | $45K | 333,863 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −161 | $558.07 | $90K | 333,702 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −168 | $558.70 | $94K | 333,534 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −71 | $559.80 | $40K | 333,463 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −517 | $561.15 | $290K | 332,946 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −512 | $562.35 | $288K | 332,434 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −291 | $563.49 | $164K | 332,143 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $564.36 | $90K | 331,983 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −220 | $565.56 | $124K | 331,763 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −300 | $566.57 | $170K | 331,463 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $567.48 | $227K | 331,063 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $569.21 | $137K | 330,823 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $570.22 | $160K | 330,543 |
Page 1 of 62 · 1,235 trades